| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 32.86B | 33.50B | 29.51B | 28.68B | 29.18B |
| Gross Profit | 8.36B | 8.71B | 7.60B | 7.04B | 7.13B |
| EBITDA | 3.08B | 3.60B | 2.83B | 4.18B | 3.62B |
| Net Income | 1.04B | 1.25B | 785.63M | 1.37B | 1.32B |
Balance Sheet | |||||
| Total Assets | 48.63B | 47.01B | 43.95B | 40.80B | 40.53B |
| Cash, Cash Equivalents and Short-Term Investments | 7.95B | 6.51B | 6.21B | 5.09B | 6.11B |
| Total Debt | 11.02B | 7.23B | 6.76B | 6.08B | 5.88B |
| Total Liabilities | 20.94B | 19.49B | 18.11B | 16.40B | 18.93B |
| Stockholders Equity | 23.48B | 23.80B | 22.28B | 21.45B | 19.49B |
Cash Flow | |||||
| Free Cash Flow | -534.10M | 480.35M | 1.34B | -1.44B | 651.23M |
| Operating Cash Flow | 2.04B | 2.08B | 3.23B | 162.21M | 1.63B |
| Investing Cash Flow | -2.58B | -1.40B | -1.53B | -1.10B | -366.57M |
| Financing Cash Flow | 1.93B | -578.51M | -535.51M | -399.08M | -732.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥24.94B | 4.94 | ― | 0.72% | 6.51% | 3.68% | |
79 Outperform | ¥11.58B | 7.94 | ― | 2.82% | 5.08% | 58.45% | |
72 Outperform | ¥174.67B | 10.51 | 10.28% | 2.77% | 4.61% | 1.98% | |
67 Neutral | ¥174.67B | 12.84 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥69.54B | 13.34 | ― | 3.09% | 7.43% | 47.68% | |
60 Neutral | ¥11.97B | 10.62 | ― | 6.70% | -1.89% | -12.80% |